Growth Hormone and Chromosome 18q- and Abnormal Growth

PHASE3CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

February 28, 2001

Primary Completion Date

June 30, 2005

Study Completion Date

June 30, 2005

Conditions
Loss of Chromosome 18qGrowth Hormone Deficiency
Interventions
DRUG

Nutropin AQ

Growth Hormone (Nutropin AQ) treatment given to Group 1 immediately Growth Hormone (Nutropin AQ) treatment given to Group 2 after one year observation

PROCEDURE

Arginine and Clonidine Stimulation Testing

This testing was done to determine growth hormone status prior to starting treatment.

PROCEDURE

Growth Factors Laboratory Testing

This involved assessment of growth factors such as IGF#1 before treatment was initiated.

PROCEDURE

Neuropsychological Testing

This testing was done prior to treatment and at the end of treatment.

Trial Locations (1)

78229-3900

The University of Texas Health Science Center at San Antonio, San Antonio

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

South Texas Veterans Health Care System

FED

collaborator

Genentech, Inc.

INDUSTRY

lead

The University of Texas Health Science Center at San Antonio

OTHER